Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Journal of Evidence-Informed Social Work
|
April 17, 2015
Characteristics and Outcomes of Young Adult Opiate Users Receiving Residential Substance Abuse Treatment
Siobhan Morse, Samuel MacMaster
Healthcare (Basel, Switzerland)
|
September 8, 2017
Decrease in Healthcare Utilization and Costs for Opioid Users Following Residential Integrated Treatment for Co-Occurring Disorders
Siobhan Morse, Brian E Bride
Postgraduate Medicine
|
November 27, 2009
Neurogenetics of dopaminergic receptor supersensitivity in activation of brain reward circuitry and relapse: proposing "deprivation-amplification relapse therapy" (DART)
Kenneth Blum, Thomas J H Chen, B William Downs, et al.
Molecular Neurobiology
|
February 29, 2012
Neuropsychopharmacology and neurogenetic aspects of executive functioning: should reward gene polymorphisms constitute a diagnostic tool to identify individuals at risk for impaired judgment?
Abdalla Bowirrat, Thomas J H Chen, Marlene Oscar-Berman, et al.
Molecular Neurobiology
|
September 28, 2011
Can the chronic administration of the combination of buprenorphine and naloxone block dopaminergic activity causing anti-reward and relapse potential?
Kenneth Blum, Thomas J H Chen, John Bailey, et al.
Postgraduate Medicine
|
November 19, 2010
Overcoming qEEG abnormalities and reward gene deficits during protracted abstinence in male psychostimulant and polydrug abusers utilizing putative dopamine D₂ agonist therapy: part 2
Kenneth Blum, Thomas J H Chen, Siobhan Morse, et al.
Journal of Addiction Research & Therapy
|
August 9, 2013
Neurogenetics and Nutrigenomics of Neuro-Nutrient Therapy for Reward Deficiency Syndrome (RDS): Clinical Ramifications as a Function of Molecular Neurobiological Mechanisms
Kenneth Blum, Marlene Oscar-Berman, Elizabeth Stuller, et al.
Journal of Psychoactive Drugs
|
March 6, 2013
Early intervention of intravenous KB220IV--neuroadaptagen amino-acid therapy (NAAT) improves behavioral outcomes in a residential addiction treatment program: a pilot study
Merlene Miller, Amanda L C Chen, Stan D Stokes, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Journal of Evidence-Informed Social Work
|
April 17, 2015
Characteristics and Outcomes of Young Adult Opiate Users Receiving Residential Substance Abuse Treatment
Siobhan Morse, Samuel MacMaster
Healthcare (Basel, Switzerland)
|
September 8, 2017
Decrease in Healthcare Utilization and Costs for Opioid Users Following Residential Integrated Treatment for Co-Occurring Disorders
Siobhan Morse, Brian E Bride
Postgraduate Medicine
|
November 27, 2009
Neurogenetics of dopaminergic receptor supersensitivity in activation of brain reward circuitry and relapse: proposing "deprivation-amplification relapse therapy" (DART)
Kenneth Blum, Thomas J H Chen, B William Downs, et al.
Molecular Neurobiology
|
February 29, 2012
Neuropsychopharmacology and neurogenetic aspects of executive functioning: should reward gene polymorphisms constitute a diagnostic tool to identify individuals at risk for impaired judgment?
Abdalla Bowirrat, Thomas J H Chen, Marlene Oscar-Berman, et al.
Molecular Neurobiology
|
September 28, 2011
Can the chronic administration of the combination of buprenorphine and naloxone block dopaminergic activity causing anti-reward and relapse potential?
Kenneth Blum, Thomas J H Chen, John Bailey, et al.
Postgraduate Medicine
|
November 19, 2010
Overcoming qEEG abnormalities and reward gene deficits during protracted abstinence in male psychostimulant and polydrug abusers utilizing putative dopamine D₂ agonist therapy: part 2
Kenneth Blum, Thomas J H Chen, Siobhan Morse, et al.
Journal of Addiction Research & Therapy
|
August 9, 2013
Neurogenetics and Nutrigenomics of Neuro-Nutrient Therapy for Reward Deficiency Syndrome (RDS): Clinical Ramifications as a Function of Molecular Neurobiological Mechanisms
Kenneth Blum, Marlene Oscar-Berman, Elizabeth Stuller, et al.
Journal of Psychoactive Drugs
|
March 6, 2013
Early intervention of intravenous KB220IV--neuroadaptagen amino-acid therapy (NAAT) improves behavioral outcomes in a residential addiction treatment program: a pilot study
Merlene Miller, Amanda L C Chen, Stan D Stokes, et al.
Page
of 1